Table 3.

Cost range for 90-day prescriptions, not including dispensing fee^*

Drug class	Generic		Brand name
	Cost rage, $	Cost variation, $	Cost range, $	Cost variation, $
Angiotensin-converting-enzyme inhibitors
Enalapril	25.73–74.01	48.28	134.64–411.03	276.39
Lisinopril	26.00–76.01	50.01	96.93–747.00	650.07
Perindopril	27.52–52.01	24.49	89.01–363.39	274.38
Ramipril	7.94–65.17	57.23	83.55–264.03	180.48
Trandolapril	22.44–56.45	34.01	87.90–150.00	62.10
Angiotensin receptor blockers
Candesartan	22.17–48.45	26.28	138.93–399.72	260.79
Valsartan	15.54–61.01	45.47	125.79–452.70	326.91
Antiplatelet agents
ASA	10.35–21.90	11.55	16.35–66.57	50.22
Clopidogrel	25.57–59.41	33.84	271.74–384.03	112.29
Direct factor Xa inhibitor
Rivaroxaban, 2.5 mg twice daily	NA	—	129.15–174.66	45.51
Statins
Atorvastatin	23.19–45.21	22.02	246.03–348.30	102.27
Rosuvastatin	19.71–50.16	30.45	198.03–291.03	93.00

ASA = acetylsalicylic acid; NA = not applicable.

^*Cost represents that of the maximum evidence-based dosage of each drug, except that the enalapril dosage was 10 mg twice daily (the American College of Cardiology guideline’s maximum dosage is 20 mg twice daily, but only for patients categorized as New York Heart Association Functional Class IV¹²), and the rivaroxaban dosage was 2.5 mg twice daily, in keeping with the COMPASS regimen therapy.¹⁴